Skip to main content
. 2022 Feb 22;17(2):e0263664. doi: 10.1371/journal.pone.0263664

Fig 1. CONRAD 90-day 1.4-gram tenofovir vaginal ring to prevent HIV used in the MTN 038 study.

Fig 1